<DOC>
	<DOCNO>NCT03098277</DOCNO>
	<brief_summary>This clinical trial study movement track device optimize monitor physical activity patient solid tumor undergo chemotherapy health care facility day without spending night . Movement track device , Microsoft Kinect 2 Microsoft Band 2 , may help doctor learn health cancer patient .</brief_summary>
	<brief_title>Movement Tracking Devices Monitor Physical Activity Patients Undergoing Chemotherapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine feasibility monitor cancer patient use wrist-worn activity monitor movement tracker . SECONDARY OBJECTIVES : I . To evaluate association activity patient report fatigue . II . To evaluate association movement incident health care intervention ( hospitalization , physical visit , intravenous hydration , etc . ) TERTIARY OBJECTIVES : I . To compare physician patient assess Eastern Cooperative Oncology Group ( ECOG ) Karnofsky performance status score data obtain movement tracker . OUTLINE : Patients perform 2 physical activity exam room record use Microsoft Kinect 2 stationary movement track device day 1 21 . The first activity rise chair , walk 10 foot , return chair . The second activity move chair step-up examination table . Patients also wear movement track wristband , Microsoft Band 2 , around wrist , complete smartphone application base patient report outcome ( PRO ) questionnaire , weigh daily 60 day . After completion study , patient follow 90 day .</detailed_description>
	<criteria>A diagnosis solid tumor , undergo palliative adjuvant therapy Undergoing least 2 planned cycle highly emetogenic chemotherapy define accord Hekseth scale ; cycle may range duration 14 day 28 day , accord standard care practice Ability understand willingness sign write informed consent Willingness wear sensor track physical activity , Global Positioning System ( GPS ) location , provide symptom rating night 60 day Able read English , Spanish , Traditional Mandarin complete patient report outcome Able ambulate without assistive device Able operate smartphone wearable wristband Patients may miss limbs Patient diagnosis hematologic malignancy Patients symptomatic brain metastasis exclude clinical trial ; asymptomatic brain metastasis permit ; permissible patient corticosteroid eliminate symptom brain metastasis Patient know movement disorder Parkinson 's disease , choreoathetoid movement disorder , essential tremor movement disorder sufficient severity require drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>